当前位置:首页 - 行情中心 - 药石科技(300725) - 财务分析 - 现金流量表

药石科技

(300725)

  

流通市值:68.42亿  总市值:78.91亿
流通股本:2.03亿   总股本:2.34亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金495,133,341.922,150,578,302.711,545,415,387.341,163,025,106.38
  收到的税费返还15,598,164.7848,860,466.1539,125,824.5833,005,462.17
  收到其他与经营活动有关的现金10,399,302.6425,386,373.9421,584,658.520,274,232.21
  经营活动现金流入小计521,130,809.342,224,825,142.81,606,125,870.421,216,304,800.76
  购买商品、接受劳务支付的现金204,066,735.81742,137,695.73461,685,552.17332,193,194.98
  支付给职工以及为职工支付的现金207,186,870.89620,770,920.6479,635,079.19332,567,330.71
  支付的各项税费26,416,136.66102,289,991.3570,952,074.8954,408,297.68
  支付其他与经营活动有关的现金27,278,523.1992,265,705.850,370,559.4630,223,025.49
  经营活动现金流出小计464,948,266.551,557,464,313.481,062,643,265.71749,391,848.86
  经营活动产生的现金流量净额56,182,542.79667,360,829.32543,482,604.71466,912,951.9
二、投资活动产生的现金流量:
  收回投资收到的现金447,847,646.793,926,728,808.222,219,896,932.131,187,030,887.08
  取得投资收益收到的现金4,022,264.0543,917,706.9313,930,353.787,139,278.89
  处置固定资产、无形资产和其他长期资产收回的现金净额372,758.83,273,678.36183,565.747,964.6
  投资活动现金流入小计452,242,669.643,973,920,193.512,234,010,851.651,194,178,130.57
  购建固定资产、无形资产和其他长期资产支付的现金90,017,060.2140,130,434.8358,136,575.4662,381,555.05
  投资支付的现金560,257,475.024,010,591,095.72,483,581,394.511,441,924,903.89
  投资活动现金流出小计650,274,535.224,150,721,530.532,541,717,969.971,504,306,458.94
  投资活动产生的现金流量净额-198,031,865.58-176,801,337.02-307,707,118.32-310,128,328.37
三、筹资活动产生的现金流量:
  取得借款收到的现金-100,000,000100,000,000-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-100,000,000100,000,000-
  偿还债务支付的现金-275,007,357.22275,007,357.2245,007,357.22
  分配股利、利润或偿付利息支付的现金543,715.4865,746,095.4769,489,134.3468,767,939.16
  支付其他与筹资活动有关的现金296,613.191,705,613.382,675,327.73885,730.15
  筹资活动现金流出小计840,328.67342,459,066.07347,171,819.29114,661,026.53
  筹资活动产生的现金流量净额-840,328.67-242,459,066.07-247,171,819.29-114,661,026.53
四、汇率变动对现金及现金等价物的影响-14,438,270.38-5,561,795.491,465,968.39-10,892
五、现金及现金等价物净增加额-157,127,921.84242,538,630.74-9,930,364.5142,112,705
  加:期初现金及现金等价物余额532,739,255.18290,200,624.44290,200,624.44290,200,624.44
  期末现金及现金等价物余额375,611,333.34532,739,255.18280,270,259.93332,313,329.44
补充资料:
  净利润-183,735,514.39-72,498,099.12
  资产减值准备-50,382,275.75-24,971,667.39
  固定资产和投资性房地产折旧-131,214,349.87-62,559,004.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-131,214,349.87-62,559,004.34
  无形资产摊销-5,810,689.86-3,059,806.06
  长期待摊费用摊销-4,312,822.09-2,126,281.52
  处置固定资产、无形资产和其他长期资产的损失--1,148,940.44--
  固定资产报废损失-2,469,194.97-1,045,646.01
  公允价值变动损失--678,192.97-434,704.1
  财务费用-38,340,714.16-26,680,460.55
  投资损失--36,281,193.53--11,059,877.09
  递延所得税--8,194,479.68--4,751,804.91
  其中:递延所得税资产减少--7,174,804.03--3,186,223.91
    递延所得税负债增加--1,019,675.65--1,565,581
  存货的减少-154,327,730.88-81,440,589.01
  经营性应收项目的减少-162,084,373.58-158,855,636.96
  经营性应付项目的增加--15,268,135.25-45,681,687.75
  其他--6,503,454.75-1,641,649.1
  现金的期末余额-532,739,255.18-332,313,329.44
  减:现金的期初余额-290,200,624.44-290,200,624.44
  现金及现金等价物的净增加额-242,538,630.74-42,112,705
公告日期2026-04-222026-04-222025-10-302025-08-08
审计意见(境内)标准无保留意见
TOP↑